Log in

Intraductal papillary neoplasm of the bile duct: diagnostic value of MRI features in differentiating pathologic subclassifications—type 1 versus type 2

  • Hepatobiliary-Pancreas
  • Published:
European Radiology Aims and scope Submit manuscript

A Commentary to this article was published on 04 January 2024

Abstract

Objectives

To identify MRI features for differentiating type 2 from type 1 intraductal papillary neoplasms of bile duct (IPNB) and assessing malignant potential of IPNB.

Methods

This retrospective study included 60 patients with surgically proven IPNB who had undergone preoperative MRI between January 2007 and December 2020. All surgical specimens were reviewed retrospectively to classify types 1 and 2 IPNBs and assess tumor grade. Significant MRI features for differentiating type 2 (n = 40) from type 1 IPNB (n = 20); and for IPNB with an associated invasive carcinoma (n = 43) from intraepithelial neoplasia (n = 17) were determined using logistic regression analysis.

Results

An associated invasive carcinoma was more frequently found in type 2 than in type 1 IPNB (85.0% [34/40] vs. 45.0% [9/20], p = 0.003). At univariable analysis, MRI features including extrahepatic location, no dilatation of tumor-bearing segment of bile duct, isolated upstream bile duct dilatation, and single lesion were associated with type 2 IPNB (all p ≤ 0.012). At multivariable analysis, significant MRI findings for differentiating type 2 from type 1 IPNB were extrahepatic location and no dilatation of tumor-bearing segment of bile duct (odds ratio [OR], 7.24 and 46.40, respectively). At univariable and multivariable analysis, tumor size ≥ 2.5 cm (OR, 8.45), bile duct wall thickening (OR, 4.82), and irregular polypoid or nodular tumor shape (OR, 6.44) were significant MRI features for differentiating IPNB with an associated invasive carcinoma from IPNB with intraepithelial neoplasia.

Conclusion

MRI with MR cholangiopancreatography may be helpful in differentiating type 2 IPNB from type 1 IPNB and assessing malignant potential of IPNB.

Clinical relevance statement

Preoperative MRI with MR cholangiopancreatography may be helpful in differentiating type 2 intraductal papillary neoplasms of bile duct (IPNB) from type 1 IPNB and assessing malignant potential of IPNB.

Key Points

In terms of tumor grade, the incidence of invasive carcinoma was significantly higher in type 2 intraductal papillary neoplasm of the bile duct (IPNB) than in type 1 IPNB.

At MRI, extrahepatic location and no dilatation of tumor-bearing segment are significant features for differentiating type 2 IPNBs from type 1 IPNBs.

At MRI, large tumor size, bile duct wall thickening, and irregular polypoid or nodular tumor shape are significant features for differentiating IPNB with an associated invasive carcinoma from IPNB with intraepithelial neoplasia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

ADC:

Apparent diffusion coefficient

CER:

Contrast enhancement ratio

CI:

Confidence interval

DWI:

Diffusion-weighted imaging

GRE:

Gradient echo

IPMN:

Intraductal papillary mucinous neoplasm

IPNB:

Intraductal papillary neoplasm of the bile duct

MRCP:

MR cholangiopancreatography

OR:

Odds ratio

RFS:

Recurrence-free survival

WHO:

World Health Organization

References

  1. Nakanuma Y, Uesaka K, Miyayama S, Yamaguchi H, Ohtsuka M (2017) Intraductal neoplasms of the bile duct. A new challenge to biliary tract tumor pathology. Histol Histopathol 32:1001–1015

    PubMed  Google Scholar 

  2. Ainechi S, Lee H (2016) Updates on precancerous lesions of the biliary tract: biliary precancerous lesion. Arch Pathol Lab Med 140:1285–1289

    Article  PubMed  Google Scholar 

  3. Nakanuma Y, Uesaka K, Kakuda Y et al (2020) Intraductal papillary neoplasm of bile duct: updated clinicopathological characteristics and molecular and genetic alterations. J Clin Med 9:3991

  4. Nakanuma Y, Jang KT, Fukushima N et al (2018) A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage. J Hepatobiliary Pancreat Sci 25:181–187

    Article  PubMed  Google Scholar 

  5. Schlitter AM, Born D, Bettstetter M et al (2014) Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways. Mod Pathol 27:73–86

    Article  CAS  PubMed  Google Scholar 

  6. Rocha FG, Lee H, Katabi N et al (2012) Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology 56:1352–1360

    Article  CAS  PubMed  Google Scholar 

  7. Kubota K, Nakanuma Y, Kondo F et al (2014) Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association. J Hepatobiliary Pancreat Sci 21:176–185

    Article  PubMed  Google Scholar 

  8. Jung G, Park KM, Lee SS, Yu E, Hong SM, Kim J (2012) Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct. J Hepatol 57:787–793

    Article  PubMed  Google Scholar 

  9. Nakanuma Y, Basturk O, Esposito I, Klimstra DS, Komuta M, Zen Y (2019) Intraductal papillary neoplasm of the bile ducts. WHO Classification of Tumours of the Digestive System 5th edition. edn. IARC, Lyon

  10. Kubota K, Jang JY, Nakanuma Y et al (2020) Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study. J Hepatobiliary Pancreat Sci 27:581–597

    Article  PubMed  Google Scholar 

  11. Joo I, Lee JM, Yoon JH (2018) Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: recent advances and challenges. Radiology 288:7–13

    Article  PubMed  Google Scholar 

  12. Joo I, Lee JM (2013) Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection. Abdom Imaging 38:1334–1350

    Article  PubMed  Google Scholar 

  13. Yoon HJ, Kim YK, Jang KT et al (2013) Intraductal papillary neoplasm of the bile ducts: description of MRI and added value of diffusion-weighted MRI. Abdom Imaging 38:1082–1090

    Article  PubMed  Google Scholar 

  14. Ohtsuka M, Shimizu H, Kato A et al (2014) Intraductal papillary neoplasms of the bile duct. Int J Hepatol 2014:459091

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kang MJ, Jang JY, Lee KB, Han IW, Kim SW (2013) Impact of macroscopic morphology, multifocality, and mucin secretion on survival outcome of intraductal papillary neoplasm of the bile duct. J Gastrointest Surg 17:931–938

    Article  PubMed  Google Scholar 

  16. Park HJ, Kim SY, Kim HJ et al (2018) Intraductal papillary neoplasm of the bile duct: clinical, imaging, and pathologic features. AJR Am J Roentgenol 211:67–75

    Article  PubMed  Google Scholar 

  17. Lee S, Kim MJ, Kim S, Choi D, Jang KT, Park YN (2019) Intraductal papillary neoplasm of the bile duct: assessment of invasive carcinoma and long-term outcomes using MRI. J Hepatol 70:692–699

    Article  PubMed  Google Scholar 

  18. Nakanuma Y, Sato Y, Ojima H et al (2014) Clinicopathological characterization of so-called “cholangiocarcinoma with intraductal papillary growth” with respect to “intraductal papillary neoplasm of bile duct (IPNB).” Int J Clin Exp Pathol 7:3112–3122

    PubMed  PubMed Central  Google Scholar 

  19. Takanami K, Yamada T, Tsuda M et al (2011) Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation. Abdom Imaging 36:447–456

    Article  PubMed  Google Scholar 

  20. Mc G, Fowler KJ, Roudenko A et al (2021) How to use LI-RADS to report liver CT and MRI observations. Radiographics 41:1352–1367

    Article  Google Scholar 

  21. Viera AJ, Garrett JM (2005) Understanding interobserver agreement: the kappa statistic. Fam Med 37:360–363

    PubMed  Google Scholar 

  22. Nakanuma Y, Kakuda Y, Uesaka K (2019) Characterization of intraductal papillary neoplasm of the bile duct with respect to the histopathologic similarities to pancreatic intraductal papillary mucinous neoplasm. Gut Liver 13:617–627

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ohtsuka M, Kimura F, Shimizu H et al (2011) Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion. Am J Surg Pathol 35:512–521

    Article  PubMed  Google Scholar 

  24. Komori T, Inoue D, Zen Y et al (2019) CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas. Eur Radiol 29:3132–3140

    Article  PubMed  Google Scholar 

  25. Nakanishi Y, Zen Y, Kawakami H et al (2008) Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases. Mod Pathol 21:807–816

    Article  CAS  PubMed  Google Scholar 

  26. Igami T, Nagino M, Oda K et al (2009) Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg 249:296–302

    Article  PubMed  Google Scholar 

  27. Yoon JH, Lee JM, Yu MH, Kim EJ, Han JK, Choi BI (2014) High-resolution T1-weighted gradient echo imaging for liver MRI using parallel imaging at high-acceleration factors. Abdom Imaging 39:711–721

    Article  PubMed  Google Scholar 

  28. Yoon JH, Nickel MD, Peeters JM, Lee JM (2019) Rapid imaging: recent advances in abdominal MRI for reducing acquisition time and its clinical applications. Korean J Radiol 20:1597–1615

    Article  PubMed  PubMed Central  Google Scholar 

  29. Yoon JH, Lee SM, Kang HJ et al (2017) Clinical feasibility of 3-dimensional magnetic resonance cholangiopancreatography using compressed sensing: comparison of image quality and diagnostic performance. Invest Radiol 52:612–619

    Article  PubMed  Google Scholar 

  30. Banales JM, Marin JJG, Lamarca A et al (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17:557–588

    Article  PubMed  PubMed Central  Google Scholar 

  31. Sakai Y, Ohtsuka M, Sugiyama H et al (2021) Current status of diagnosis and therapy for intraductal papillary neoplasm of the bile duct. World J Gastroenterol 27:1569–1577

    Article  PubMed  PubMed Central  Google Scholar 

  32. Lim JH, Yi CA, Lim HK, Lee WJ, Lee SJ, Kim SH (2002) Radiological spectrum of intraductal papillary tumors of the bile ducts. Korean J Radiol 3:57–63

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2020R1A2C2006031).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeong Min Lee.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Jeong Min Lee.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

This study was approved by the Institutional Review Board of Seoul National University Hospital (IRB No. H-1911–077-1078).

Ethical approval

Institutional Review Board approval was obtained.

Study subjects or cohorts overlap

Not applicable.

Methodology

• retrospective

• observational

• performed at one institution

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 148 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jeon, S.K., Lee, J.M., Yoo, J. et al. Intraductal papillary neoplasm of the bile duct: diagnostic value of MRI features in differentiating pathologic subclassifications—type 1 versus type 2. Eur Radiol 34, 4674–4685 (2024). https://doi.org/10.1007/s00330-023-10491-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-10491-9

Keywords

Navigation